PCH
ACET icon

Polar Capital Holdings’s Adicet Bio ACET Stock Holding History

Polar Capital Holdings’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-78,989
Closed -$7.28M – 288
2023
Q1 		$7.28M Hold
78,989
– – 0.05% 212
2022
Q4 		$11.3M Sell
78,989
-1,865
-2% -$465K 0.09% 185
2022
Q3 		$18.4K Sell
80,854
-15,625
-16% -$3.97M 0.12% 150
2022
Q2 		$22.5K Hold
96,479
– – 0.13% 134
2022
Q1 		$30.8K Buy
96,479
+1,024
+1% +$236K 0.14% 130
2021
Q4 		$26.7K Buy
+95,455
New +$16.4M 0.11% 148

Other funds holding ACET

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return